|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Approves Pfizer’s Breast Cancer Treatment
2
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
3
Q&A: Why Pharma Deal Volume Is Down but Value Is Up
4
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
5
